A surge in prostate cancer cases is anticipated, prompting planning and discussion among medical professionals. Various studies and initiatives are underway to address prostate cancer, including research on diagnosis, treatment, and recurrence. The Lancet Commission on prostate cancer is involved in these efforts, with experts contributing to a global plan to combat the disease.